Reuters logo
BRIEF-Valeant Pharmaceuticals plans to invest in Salix - CEO
December 14, 2016 / 7:06 PM / a year ago

BRIEF-Valeant Pharmaceuticals plans to invest in Salix - CEO

Dec 14 (Reuters) - Valeant Pharmaceuticals International Inc CEO Joe Papa, speaking at BMO investor conference in New York:

* Said Valeant plans to invest in its Salix business, a core asset Further company coverage: (Reporting By Rod Nickel)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below